Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-118032 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 20, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
7,500
Total Value
$320,627.15
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 20, 2026 | Exercise/Conversion | 2,500 | $49.10 | $122,750.00 | 2,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 20, 2026 | Sale | 700 | $77.71 | $54,397.77 | 1,800 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 20, 2026 | Sale | 600 | $79.24 | $47,546.34 | 1,200 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 20, 2026 | Sale | 1,200 | $79.94 | $95,933.04 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 20, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details |